Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in cancer patients may vary widely dependent on the geographic area and this has significant implications for oncological care. The aim of this observational, prospective study was to assess the seroprevalence of SARS-CoV-2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Cantini, Luca, Bastianelli, Lucia, Lupi, Alessio, Pinterpe, Giada, Pecci, Federica, Belletti, Giovanni, Stoico, Rosa, Vitarelli, Francesca, Moretti, Marco, Onori, Nicoletta, Giampieri, Riccardo, Rocchi, Marco Bruno Luigi, Berardi, Rossana
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038489/
https://ncbi.nlm.nih.gov/pubmed/33916569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados